As the CEO and co-founder of NUAgo Therapeutics, I lead a biotechnology company that leverages cutting-edge science and technology to develop innovative therapies for unmet medical needs. With over 15 years of experience in the life sciences industry, I have a strong track record of delivering value and growth for clients and partners across biotechnology, pharmaceutical, and medical device sectors.My core competencies include scientific and technology assessment, M&A due diligence, portfolio strategy, BD&L analysis, growth and marketing strategies, and advisory board membership. I have completed over 100 asset valuation and portfolio assessment projects, analyzed or led more than 100 disease area landscapes and market assessment opportunities, and built integrated global and regional corporate and commericial strategies for various life sciences companies. I have also published multiple peer-reviewed papers in prestigious journals, demonstrating my deep understanding of the scientific and clinical aspects of drug discovery and development. I am passionate about advancing the field of biotechnology and creating positive impact for patients and society.